1. 2019
  2. Adult human pancreatic acinar cells dedifferentiate into an embryonic progenitor-like state in 3D suspension culture

    Baldan, J., Houbracken, I., Rooman, I. & Bouwens, L., 11 Mar 2019, In : Scientific Reports - Nature. 9, 1, p. 1-12 12 p., 4040.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Phase I clinical trial of decitabine (5-aza-2 '-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases

    Jansen, Y. J. L., Verset, G., Schats, K., Van Dam, P-J., Seremet, T., Kockx, M., Van Laethem, J-L. B. & Neyns, B., Mar 2019, In : ESMO Open. 4, 2, e000464.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Emotional and cognitive disturbances in long-term melanoma survivors treated with ipilimumab

    Rogiers, A. I., Awada, G., Schwarze, J. K., Ben Salama, L., Theuns, P., De Cremer, J. & Neyns, B., 28 Feb 2019, Emotional and cognitive disturbances in long-term melanoma survivors treated with ipilimumab.

    Research output: Chapter in Book/Report/Conference proceedingMeeting abstract (Book)Research

  5. Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation

    Gauci, M-L., Lanoy, E., Champiat, S., Caramella, C., Ammari, S., Aspeslagh, S., Varga, A., Baldini, C., Bahleda, R., Gazzah, A., Michot, J-M., Postel-Vinay, S., Angevin, E., Ribrag, V., Hollebecque, A., Soria, J-C., Robert, C., Massard, C. & Marabelle, A., 1 Feb 2019, In : Clinical Cancer Research. 25, 3, p. 946-956 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma

    Seremet, T., Planken, S., Schwarze, J. K., Jansen, Y., Vandeweerd, L., van den Begin, R., Tsechelidis, I., Lienard, D., Del Marmol, V. & Neyns, B., Feb 2019, In : Melanoma Research. 29, 1, p. 85-88 4 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Supportieve zorg bij de behandeling met immuuncheckpointinhibitoren

    Awada, G., Rogiers, A. I. & Neyns, B., 9 Jan 2019, In : OncoHemato. 12, 7, p. 39-50

    Research output: Contribution to journalArticleResearchpeer-review

  8. Cancer-associated cachexia, reactive oxygen species, and nutrition therapy

    Bjorklund, G., Dadar, M., Aaseth, J., Chirumbolo, S. & Pen, J. J., 2019, In : Current Medicinal Chemistry. 26, 31, p. 5728-5744 17 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Energy expenditure of patients on ECMO: A prospective pilot study

    De Waele, E., Jonckheer, J., Pen, J. J., Demol, J., Staessens, K., Puis, L., La Meir, M., Honoré, P. M., L N G Malbrain, M. & Spapen, H. D., 2019, In : Acta Anaesthesiologica Scandinavica. 63, 3, p. 360-364 5 p.

    Research output: Contribution to journalArticleResearchpeer-review

  10. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review

    de Filette, J. M. K., Pen, J. J., Decoster, L., Vissers, T., Bravenboer, B., Van der Auwera, B. J., Gorus, F., Roep, B. O., Aspeslagh, S., Neyns, B., Velkeniers, B. & Kharagjitsingh, A. V., 2019, In : European Journal of Endocrinology. 181, p. 363-374

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 25692